Total knee arthroplasty has proven effective in the treatment of primary osteoarthrosis in elderly patients. In an attempt to avoid performing total knee arthroplasty in younger patients with painful, debilitating osteoarthrosis, various treatment options historically have been offered. 14,18,25,28,34 Nonsurgical interventions, such as nonsteroidal antiinflammatory medications, hyaluronic acid or corticosteroid injections, and glucosamine and chondroitin Sulfate supplementation, all have been used in young patients with mixed results. 1,2,7,9,14,15,19,24,29,33,34 Additionally, nonprosthetic surgical options such as arthroscopic lavage or debridement, periarticular osteotomy, and arthrodesis, have a role in a select group of patients although the results tend to deteriorate with time. 3,18,25
Total knee arthroplasty has been shown to be effective in patients 55 years of age and younger, in those patients with rheumatoid arthritis, and in patients with osteoarthritis. 10,12, 13,16,26,30 The concern in the orthopaedic community of accelerated failure in young, active patients because of repetitive loading, or presumed difficulty in performing the inevitable revisions, has prompted many surgeons to arbitrarily reserve total knee arthroplasty for those patients approaching or older than 65 years of age. It is being more commonly observed that many young patients present with severe debilitating arthrosis, which may not be amenable to surgical interventions other than total knee arthroplasty. It is the purpose of the current study to specifically address the results of total knee arthroplasty, after a minimum of 5-year followup, in patients who are younger than 40 years of age who have osteoarthrosis.
MATERIALS AND METHODS
A letter was sent to members of the Knee Society, soliciting data on patients, 40 years of age or younger, who underwent total knee arthroplasty for osteoarthrosis and were followed up for at least 5 years. Complete data, excluding those young patients who underwent total knee arthroplasty for inflammatory arthritis or secondary to fracture, were available for 44 patients from five centers. In this collected series of patients, 12 patients with Porous Coated Anatomic arthroplasties (Howmedica, Rutherford NJ) were excluded from analysis in the study because failures of this prosthesis likely were not related to patient age per se, but more to flaws in material qualities and design of the implant that ultimately have lead to its removal from the consumer market. The implants in nine of those 12 patients failed because of polyethylene wear and component loosening. This leaves 32 knees for inclusion in this study.
The average patient age was 35 years (range, 22–40 years). There were 13 women. The average height of the patients was 69 inches (range, 62–78 inches). The average weight of the patients was 200 lb (range, 109–380 lb). The average body mass index ([703 × weight]/height2) was 29.5. This suggests that the average patient was not by definition considered to be obese. All patients had either primary osteoarthrosis or posttraumatic arthrosis secondary to ligament injury. Eleven patients were receiving worker’s compensation related to injuries that eventually lead to arthrosis. Seventy-one prior surgeries were performed in 26 patients (mean, 2.7 surgeries per patient; range, 0–17 surgeries).
Total knee arthroplasties were performed between 1982 and 1994. Implants included Series 7000 (Osteonics, Allendale, NJ, n = 3), Insall-Burstein II (Zimmer, Warsaw, IN, n = 4), Anatomic Gradiated Component (Biomet, Warsaw, IN, n = 13), Duracon (Howmedica, Rutherford, NJ, n = 3), Press-Fit condylar (Johnson & Johnson/DePuy, Warsaw, IN, n = 7), Maxim (Biomet, n = 1), and Techmedica (Sulzer Orthopaedics, Hampshire, United Kingdom, n = 1).
The tibial and femoral components were cemented in 27 knees; two patients had hybrid fixation (tibia cemented, femur uncemented); and three were uncemented. Patellar resurfacing was performed in 28 of the 32 patients.
RESULTS
Preoperative flexion contractures averaged 8° (range, 0°–30°). Flexion arc averaged 92° (range, 20°–125°). Preoperative Knee Society knee scores 17 averaged 47 points (range, 5–80 points). Preoperative function scores averaged 45 points (range, 5–70 points).
Followup averaged 7.9 years (range, 5–17 years). Postoperative flexion contractures decreased to an average of 1.5° (range, 0°–20°). Flexion arc increased to 110° (range, 80°–130°). Postoperative Knee Society knee scores averaged 88 points (range, 53–96 points) and function scores averaged 70 points (range, 35–100 points).
Three revisions had been performed for polyethylene wear and loosening, at a mean 8-year interval after component implantation. Prostheses revised for aseptic loosening included Anatomic Gradiated Component (n = 1, 2 years), Insall-Burstein II (n = 1, 7 years), and Osteonics (n = 1, 5 years). One implant has been revised for infection. An additional patient has evidence of complete lucency beneath the tibial component, but revision has not yet been performed. Two of the aseptic failures occurred with cemented components; two occurred with cementless components. Using revision for aseptic failure as an endpoint, implant survival in this patient population at 8 years is 90.6%. Using radiographic loosening as an endpoint, aseptic failures occurred in 12.5% implants at 8 years. Aseptic failures occurred in two of the three cementless tibial implants and only two of the 29 cemented tibial implants.
Incomplete radiographic loosening beneath the tibial tray was observed in one patient. One patient required two neurectomies for neurogenic pain. One patient underwent successful treatment of a supracondylar femur fracture, but required three manipulations under anesthesia for arthrofibrosis. Eleven manipulations under anesthesia were necessary in patients in the current series. Patellar realignment was necessary in one patient.
Overall, Knee Society knee scores were considered good or excellent in 82% of patients and fair or poor in 18%. Postoperative function scores were good or excellent in only 40%.
When patients involved in worker’s compensation cases are excluded from the analysis, the results improved substantially, with range of motion (ROM) averaging 113°, Knee Society knee score averaging 92 points, and function score averaging 77 points. Excluding patients involved in worker’s compensation cases, knee scores were good or excellent in 91% of patients and function scores were good or excellent in 50% of patients.
There did not seem to be an association between the likelihood of unsuccessful results and prior surgeries, particularly proximal tibial osteotomy or patellectomy. One patient, who had an infection develop postoperatively, had a prior anterior cruciate ligament reconstruction and Maquet tibial tubercle osteotomy through separate incisions.
DISCUSSION
Total knee arthroplasty has proven effective long-term for elderly patients with osteoarthrosis. 27,31 Our highly active and athletically oriented society has promoted a population at risk for ligamentous and chondral injuries in young patients that ultimately may induce chondral degeneration in this young patient population. 21,22 Young patients with debilitating osteoarthrosis present a different challenge than those patients with rheumatoid arthritis, attendant to their higher activity levels. Concerns about component wear and implant longevity in this young group of patients have led many orthopaedic surgeons to withhold arthroplasty and to recommend other less predictable surgical and nonsurgical alternatives for this group of patients. 4 Often times, when total knee arthroplasty is pursued, knees have multiple scars, arthrofibrosis, and malalignment that ultimately make arthroplasty technically more challenging and may compromise results.
Although several articles have addressed the issue of total knee arthroplasty for patients younger than 55 years, to the authors’ knowledge, no other study specifically has addressed the role of total knee arthroplasty in patients younger than 40 years of age. 8,10,12,26 The current series has shown that the followup Knee Society scores and function in this young group of patients is inferior to those scores observed in the more elderly counterparts. Some of this may be related to unreasonable expectations of the patients and to the reality of inferior results of total knee arthroplasty often observed in knees with multiple scars or arthrofibrosis. 20 It is important to consider that these patients present some of the most difficult challenges in knee surgery—“easy” cases of osteoarthrosis in patients younger than 40 years generally are treated with nonarthroplasty options, such as distal femoral or proximal tibial osteotomies. Therefore, the results presented in the current series of 32 knees should be considered successful. If one excludes the excessive rate of failures observed in the presence of cementless tibial components, the option of total knee arthroplasty becomes even more attractive in this group of patients. In the entire series of young, active patients, the results of arthroplasty met or exceeded the expectations of 83% of the patients; 17% of patients were disappointed.
The issue of poor results in patients receiving worker’s compensation has been elaborated by Mont et al. 23 In a series of 42 patients who underwent total knee arthroplasty, the results at a mean followup of 80 months were significantly worse (p < 0.01) in those patients receiving compensation compared with those who were not receiving compensation. Despite similar objective parameters in ROM, stability, and radiographic alignment, subjective scores were significantly inferior. The results in the current series corroborate those findings.
Diduch et al 10 reviewed the results of 103 knees using one implant in patients 55 years of age or younger for osteoarthrosis or posttraumatic arthrosis. No distinction was made regarding age categories. At a mean followup of 8 years, the average Knee Society knee score was 94 points, and the average functional score was 89 points. The authors reported an overall anticipated 18-year survival rate of 94%, although when patellar revision or spacer exchange were included in failures, expected survivorship was reduced to 87% at 18 years. 10 Activity level, according to the scoring system of Tegner and Lysholm 32 were improved in all but two patients.
In a separate study of total knee arthroplasties in patients younger than 55 years of age, Ranawat et al 26 analyzed 93 total knee arthroplasties in 62 patients. Seventy-six patients had rheumatoid arthritis and 17 had osteoarthritis. The authors did not subdivide the patients according to age or activity level. However, good or excellent results were observed in 94% of patients with osteoarthritis and in 99% of those with rheumatoid arthritis at a mean followup of 6.1 years. Ninety-six percent survivorship was observed at 10 years using an endpoint of clinical or radiologic failure.
Duffy et al 12 reported the results of 74 consecutive total knee arthroplasties in 54 patients who were 55 years of age or younger. Only 18 patients had a diagnosis of osteoarthrosis or posttraumatic arthrosis with the remainder having inflammatory or infectious arthritis. The authors reported a final Knee Society knee score of 84 points, and functional score of 60 points at a minimum 10-year followup. Two revisions were necessary either because of ligamentous laxity or aseptic loosening. Implant survivorship at 10 years was estimated to be 99% and at 15 years implant survivorship was 95%. These data are comparable with data observed in the current series, although there was no distinction made in the results between those patients who had inflammatory arthritides or osteoarthrosis. Additionally in the series by Duffy et al, 12 all implants were cemented.
Dalury et al 8 reviewed 103 total knee arthroplasties in patients younger than 45 years of age. Once again, the majority of patients had rheumatoid arthritis (87%), with only a small proportion having osteoarthrosis. No distinction was made between the results in patients with inflammatory arthritis and osteoarthritis. At a mean followup of 7.2 years, no revisions were necessary for aseptic failure, but three revisions were necessary for patella failures and one for infection.
Coyte et al 6 reviewed the hospitalization statistics for 1301 revision total knee arthroplasties performed in Ontario, Canada between 1984 and 1991. They found that rheumatoid arthritis was associated with the lowest rate of revision (p = 0.03) and that young age (55 or younger) was associated with the shortest implant survival time (p < 0.0001). Patients who were 55 years of age had the greatest risk for implant failure; patients who were 65 years of age had a relative 85% risk of implant failure compared with the 55-year-old patients; and the patients who were 75 years of age had a 60% risk of failure relative to the 55-year-old patients. However, the authors also reported that the overall survivorship was so high (92% to 96%) that these differences were quantitatively small in relationship to the entire population of patients undergoing total knee arthroplasty. 6
The current results suggest that total knee arthroplasty for patients younger than 40 years of age may provide pain relief and return to functional activity, but results are slightly inferior to those observed in the elderly population. However, these patients are the most severely affected, with gonarthrosis not amenable to realignment procedures. In the current series various implants had been used and failures seemed to be related to older implant designs with poor material properties or the use of cementless components. Multiple prior surgeries did not seem to affect the overall results. Prior proximal tibial osteotomy did not effect outcomes in this group of patients.
Unlike total hip arthroplasty for very young patients, cemented total knee arthroplasty may produce excellent mid-and long-term results in patients younger than 40 years of age with end-stage arthrosis, provided they are willing to modify their activity levels. 5,11 However, nonoperative interventions should be used at all costs until they are no longer effective. Additionally, other nonarthroplasty surgical options can be considered. Arthroscopic debridement and lavage, however, have provided variable pain relief. 3 For those patients with considerable limb malalignment, and unicompartmental disease, and for those patients who wish to continue working in labor-intensive jobs or continue their athletic involvement periarticular osteotomy or fusion (rarely) should be offered and encouraged before total knee arthroplasty. Today, most patients will not consent to arthrodesis. Proximal tibial osteotomy or distal femoral osteotomy for patients with unicompartmental arthrosis with malalignment of the mechanical axis may provide 60% to 65% satisfactory short-term results; however, deterioration of results beyond 5 years is common. 18,25 Unicompartmental arthroplasty in young active patients has been fraught with complications, including accelerated failures. 28
Despite a slightly higher tendency for aseptic failures in this group of patients, cemented total knee arthroplasty may provide some patients younger than 40 years of age, who have severe debilitating and recalcitrant osteoarthrosis, an important option with reasonable mid-and long-term results. Appropriate counseling before surgery regarding expectations and the possibility of eventual failure is important. Enhancing implant longevity in this group of patients is predicted on appropriate surgical technique, using carefully selected implants of acceptable design and material properties, and limiting the activity levels of these young patients.
Acknowledgments
The authors thank David Hungerford, MD; Kenneth Krackow, MD; Roger Emerson, MD; William Head, MD; Merrill Ritter, MD; Philip Faris, MD; E. Michael Keating, MD; Victor Goldberg, MD; and Adolf Lombardi, MD, who submitted cases for use in this series.
References
1. Adams ME, Atkinson MH, Lussier AJ, et al: The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: A Canadian multicenter trial comparing hylan G-F along, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 3:213–25, 1995.
2. Altman RD, Moskowitz R: Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: A randomized clinical trial. Hyalgan Study Group (published erratum appears in J Rheumatol 26:1216, 1999). J Rheumatol 25:2203–2212, 1998.
3. Bert JM, Maschka K: The arthroscopic treatment of unicompartmental gonarthrosis. A 5 year follow-up study of abrasion arthroplasty plus arthroscopic debridement and arthroscopic debridement alone. Arthroscopy 5:25–32, 1989.
4. Blounn GW, Walker PS, Joshi A, Hardinge K: The dominance of cyclic sliding in producing wear in total knee replacements. Clin Orthop 273:253–260, 1991.
5. Chandler HP, Reineck FT, Wixson RL, McCarthy JC: Total hip replacement in patients younger than 30 years old. J Bone Joint Surg 63A:1426–1434, 1981.
6. Coyte PC, Hawker G, Croxford R, Wright JG: Rates of revision knee replacement in Ontario, Canada. J Bone Joint Surg 81A:773–782, 1999.
7. Creamer P: Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol 11:417–21, 1999.
8. Dalury DF, Ewald FC, Christie MJ, Scott RD: Total knee arthroplasty in a group of patients less than 45 years of age. J Arthroplasty 10:598–602, 1995.
9. Deal CL, Moskowitz RW: Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am 25:379–95, 1999.
10. Diduch DR, Insall JN, Scott WN, et al: Total knee replacement in young, active patients. Long-term follow-up and functional outcome. J Bone Joint Surg 79A:575–582, 1997.
11. Dorr LD, Takei GK, Conaty JP: Total hip arthroplasties in patients less than 45 years old. J Bone Joint Surg 65A:474–479, 1983.
12. Duffy GP, Trousdale RT, Stuart MJ: Total knee arthroplasty in patients 55 years old or younger: 10 to 17 year results. Clin Orthop 356:22–27, 1998.
13. Ewald F, Christie MJ: Results of cemented total knee replacement in young patients. Orthop Trans 11:442, 1987.
14. Gaffney K, Ledingham J, Perry JD: Intra-articular triamcinolone hexacetonide in knee osteoarthritis: Factors influencing the clinical response. Ann Rheum Dis 54:379–81, 1995.
15. Golden BD, Abramson SB: Selective cyclooxygenase-2 inhibitors. Rheum Dis Clin North Am 25:359–378, 1999.
16. Hungerford DS, Krackow KA, Kenna RV: Cementless total knee replacement in patients 50 years old and under. Orthop Clin North Am 20:131–145, 1989.
17. Insall IN, Dorr LD, Scott RD, Scott WN: Rationale of the Knee Society clinical rating system. Clin Orthop 248:13–14, 1989.
18. Insall JN, Joseph DM, Masika C: High tibial osteotomy for varus gonarthrosis. A long term follow-up study. J Bone Joint Surg 66A:1040–1048, 1984.
19. Lefkowith JB: Cyclooxygenase-2 specificity and its clinical implications. Am J Med 106 (Suppl):43S–50S, 1999.
20. Lonner JH, Pedlow FX, Siliski JM: Total knee arthroplasty for posttraumatic arthrosis of the knee. J Arthroplasty 14:969–975, 1999.
21. McDaniel Jr WJ, Dameron Jr TB: The untreated anterior cruciate ligament rupture. Clin Orthop 172:158–163, 1983.
22. Messner K, Maletius W: The long-term prognosis for severe damage to weight-bearing cartilage in the knee. Acta Orthop Scand 67:165–168, 1996.
23. Mont MA, Mayerson JA, Krackow KA, Hungerford DS: Total knee arthroplasty in patients receiving worker’s compensation. J Bone Joint Surg 80A:1285–1290, 1998.
24. Muller-Fassbender H, Bach GL, Haase W, et al: Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage 2:61–69, 1994.
25. Nagle A, Insall JN, Scuderi GR: Proximal tibial osteotomy. A subjective outcome study. J Bone Joint Surg 78A:1353–1358, 1996.
26. Ranawat CS, Padgett DE, Ohashi Y: Total knee arthroplasty for patients younger than 55 years. Clin Orthop 248:27–33, 1989.
27. Ritter MA, Herbst SA, Keating EM, et al: Long-term survival analysis of a posterior cruciate-retaining total condylar total knee arthroplasty. Clin Orthop 309:136–145, 1994.
28. Schai PA, Suh JT, Thornhill TS, Scott RD: Unicompartmental knee arthroplasty in middle aged patients: a two to six year follow-up evaluation. J Arthroplasty 13:365–372, 1998.
29. Simon LS: Viscosupplementation therapy with intra-articular hyaluronic acid. Fact or fantasy? Rheum Dis Clin North Am 25:345–57, 1999.
30. Stern SH, Bowen MK, Insall JN, Scuderi GR: Cemented total knee arthroplasties for gonarthrosis in patients 55 years old or younger. Clin Orthop 260:124–129, 1990.
31. Stern SH, Insall JN: Posterior stabilized prostheses. Results after follow-up of nine to twelve years. J Bone Joint Surg 74A:980–986, 1992.
32. Tegner Y, Lysholm J: Rating systems and evaluation of knee ligament injury. Clin Orthop 198:43–49, 1985.
33. Towheed TE: Glucosamine sulphate in osteoarthritis: A systematic review. Arthritis Rheum 41 (Suppl): S198–S205, 1998.
34. Williams HJ, Ward JR, Egger MJ, et al: Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 36:1196–206, 1993.
Section Description
William L. Healy, MD; and Richard S. Laskin, MD Guest Editors